Skip to main content

Liver Tumor I: Benign Tumors and Tumor-Like Lesions

  • Chapter
  • First Online:

Abstract

Compared to malignant tumors, benign tumors of the liver are encountered rarely in daily practice, although their true incidence is probably not low [1]. This is because they are either asymptomatic and not discovered or they are not biopsied and left unresected. However, ultrasonographic imaging often may show benign tumors in the liver. Some of these tumors are true neoplasms, while others are tumor-like masses (Table 16.1) [2].

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Abbreviations

AFP:

Alpha-fetoprotein

AML:

Angiomyolipoma

BDA:

Bile duct adenoma

CEA:

Carcinoembryonic antigen

c-myc:

Cancer-myelocytomatosis

ELISA:

Enzyme-linked immunosorbent assay

FNH:

Focal nodular hyperplasia

HCA:

Hepatocellular adenoma

HCC:

Hepatocellular carcinoma

HMB45:

Human melanoma black 45

HNF-1:

Hepatocyte nuclear factor 1

IL6ST:

Interleukin 6 signal transducer

IPN:

Intraductal papillary neoplasm

IPT:

Inflammatory pseudotumor

L-FABP:

Liver fatty acid binding protein

LMS:

Larva migrans syndrome

MCN:

Mucinous cystic neoplasm

p53:

53-kilodalton protein

PECOMA:

Perivascular epithelioid cell tumors

PIVKA2:

Protein induced by vitamin K absence or antagonist-2

References

  1. Goodman ZD. Benign tumors of the liver. In: Okuda K, Ishak KG, editors. Neoplasms of the liver. Berlin: Springer; 1988. p. 105–25.

    Google Scholar 

  2. Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system. 4th ed. Lyon: International Agency for Research on Cancer; 2010.

    Google Scholar 

  3. Shimizu M, Miura J, Itoh H, Saitoh Y. Hepatic giant cavernous hemangioma with microangiopathic hemolytic anemia and consumption coagulopathy. Am J Gastroenterol. 1990;85:1411–3.

    CAS  PubMed  Google Scholar 

  4. Kim GE, Thung SN, Tsui WM, Ferrell LD. Hepatic cavernous hemangioma: underrecognized associated histologic features. Liver Int. 2006;26:334–8.

    PubMed  Google Scholar 

  5. Lehmann FS, Beglinger C, Schnabel K, Terraciano L. Progressive development of diffuse liver angiomatosis. J Hepatol. 1999;30:951–4.

    CAS  PubMed  Google Scholar 

  6. Ryan RM, Buelow B, Mather C, et al. Hepatic small vessel neoplasm, a rare infiltrative vascular neoplasm of uncertain malignant potential. Hum Pathol. 2016;54:143–51.

    Google Scholar 

  7. Song JS, Kim YN, Moon WS. A sclerosing hemangioma of the liver. Clin Mol Hepatol. 2013;19:426–30.

    PubMed  PubMed Central  Google Scholar 

  8. Yamashita Y, Shimada M, Taguchi K, Gion T, Hasegawa H, Utsunomiya T, et al. Hepatic sclerosing hemangioma mimicking a metastatic liver tumor: report of a case. Surg Today. 2000;30:849–52.

    CAS  PubMed  Google Scholar 

  9. Lee VT, Magnaye M, Tan HW, Thng CH, Ooi LL. Sclerosing haemangioma mimicking hepatocellular carcinoma. Singap Med J. 2005;46:140–3.

    CAS  Google Scholar 

  10. Makhlouf HR, Ishak KG. Sclerosed hemangioma and sclerosing cavernous hemangioma of the liver: a comparative clinicopathologic and immunohistochemical study with emphasis on the role of mast cells in their histogenesis. Liver. 2002;22:70–8.

    PubMed  Google Scholar 

  11. Stocker JT, Ishak KG. Focal nodular hyperplasia of the liver: a study of 21 pediatric cases. Cancer. 1981;48:336–45.

    CAS  PubMed  Google Scholar 

  12. Paradis V, Laurent A, Flejou JF, Vidaud M, Bedossa P. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X chromosome inactivation. Hepatology. 1997;26:891–5.

    CAS  PubMed  Google Scholar 

  13. Wanless I, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology. 1985;5:1194–200.

    CAS  PubMed  Google Scholar 

  14. Nguyen BN, Fléjou JF, Terris B, Belghiti J, Degott C. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol. 1999;23:1441–54.

    CAS  PubMed  Google Scholar 

  15. Paradis V, Benzekri A, Dargère D, Bièche I, Laurendeau I, Vilgrain V, et al. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology. 2004;126:1323–9.

    PubMed  Google Scholar 

  16. Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43:515–24.

    CAS  PubMed  Google Scholar 

  17. Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Sa Cunha A, Rullier A, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46:740–8.

    CAS  PubMed  Google Scholar 

  18. Govindarajan S, Peters RL. The bile duct adenoma. A lesion distinct from Meyenburg complex. Arch Pathol Lab Med. 1984;108:922–4.

    CAS  PubMed  Google Scholar 

  19. Allaire GS, Rabin L, Ishak KG, Sesterhenn IA. Bile duct adenoma: a study of 152 cases. Am J Surg Pathol. 1988;12:708–15.

    CAS  PubMed  Google Scholar 

  20. Bhathal PS, Hughes NR, Goodman ZD. The so-called bile duct adenoma is a peribiliary gland hamartoma. Am J Surg Pathol. 1996;20:858–64.

    CAS  PubMed  Google Scholar 

  21. Colombari R, Tsui WM. Biliary tumors of the liver. Semin Liver Dis. 1995;15:402–13.

    CAS  PubMed  Google Scholar 

  22. Tsui WM, Loo KT, Chow LT, Tse CC. Biliary adenofibroma. A heretofore unrecognized benign biliary tumor of the liver. Am J Surg Pathol. 1993;17:186–92.

    CAS  PubMed  Google Scholar 

  23. Varnholt H, Vauthey JN, Dal Cin P, Marsh Rde W, Bhathal PS, Hughes NR, et al. Biliary adenofibroma: a rare neoplasm of bile duct origin with an indolent behavior. Am J Surg Pathol. 2003;27:693–8.

    PubMed  Google Scholar 

  24. Arnason T, Borger DR, Corless C, Hagen C, Iafrate AJ, Makhlouf H, Misdraji J, Sapp H, Tsui WM, Wanless IR, Zuluaga Toro T, Lauwers GY. Biliary adenofibroma of liver: morphology, tumor genetics, and outcomes in 6 cases. Am J Surg Pathol. 2017;41:499–505.

    PubMed  Google Scholar 

  25. Thai E, Dalla Valle R, Evaristi F, Silini EM. A case of biliary adenofibroma with malignant transformation. Pathol Res Pract. 2016;212:468–70.

    PubMed  Google Scholar 

  26. Thompson SM, Zendejas-Mummert B, Hartgers ML, Venkatesh SK, Smyrk TC, Mahipal A, Smoot RL. Malignant transformation of biliary adenofibroma: a rare biliary cystic tumor. J Gastrointest Oncol. 2016;7:E107–12.

    PubMed  PubMed Central  Google Scholar 

  27. Albores-Saavedra J, Hoang MP, Murakata LA, Sinkre P, Yaziji H. Atypical bile duct adenoma, clear cell type: a previously undescribed tumor of the liver. Am J Surg Pathol. 2001;25:956–60.

    CAS  PubMed  Google Scholar 

  28. Ishak KG, Willis GW, Cummins SD, Bullock AA. Biliary cystadenoma and cystadenocarcinoma: report of 14 cases and review of the literature. Cancer. 1977;39:322–38.

    CAS  PubMed  Google Scholar 

  29. Wheeler DA, Edmondson HA. Cystadenoma with mesenchymal stroma (CMS) in the liver and bile ducts. A clinicopathologic study of 17 cases, 4 with malignant change. Cancer. 1985;56:1434–45.

    CAS  PubMed  Google Scholar 

  30. Devaney K, Goodman ZD, Ishak KG. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol. 1994;18:1078–91.

    CAS  PubMed  Google Scholar 

  31. Subramony C, Herrera GA, Turbat-Herrera EA. Hepatobiliary cystadenoma. A study of five cases with reference to histogenesis. Arch Pathol Lab Med. 1993;117:1036–42.

    CAS  PubMed  Google Scholar 

  32. Terada T, Kitamura Y, Ohta T, Nakanuma Y. Endocrine cells in hepatobiliary cystadenomas and cystadenocarcinomas. Virchows Arch. 1997;430:37–40.

    CAS  PubMed  Google Scholar 

  33. Kim YI, Kim ST, Lee GK, Choi BI. Papillary cystic tumor of the liver. Cancer. 1990;65:2740–6.

    CAS  PubMed  Google Scholar 

  34. Nakanuma Y, Sasaki M, Terada T, Harada K. Intrahepatic peribiliary glands of humans. II. Pathological spectrum. J Gastroenterol Hepatol. 1994;9:80–6.

    CAS  PubMed  Google Scholar 

  35. Madden JJ Jr, Smith GW. Multiple biliary papillomatosis. Cancer. 1974;34:1316–20.

    PubMed  Google Scholar 

  36. Chen TC, Nakanuma Y, Zen Y, Chen MF, Jan YY, Yeh TS, et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology. 2001;34:651–8.

    CAS  PubMed  Google Scholar 

  37. Kim YS, Myung SJ, Kim SY, Kim HJ, Kim JS, Park ET, et al. Biliary papillomatosis: clinical, cholangiographic and cholangioscopic findings. Endoscopy. 1998;30:763–7.

    CAS  PubMed  Google Scholar 

  38. Tsui WM, Lam PW, Mak CK, Pay KH. Fine-needle aspiration cytologic diagnosis of intrahepatic biliary papillomatosis (intraductal papillary tumor): report of three cases and comparative study with cholangiocarcinoma. Diagn Cytopathol. 2000;22:293–8.

    CAS  PubMed  Google Scholar 

  39. Nakanuma Y, Sasaki M, Ishikawa A, Tsui W, Chen TC, Huang SF. Biliary papillary neoplasm of the liver. Histol Histopathol. 2002;17:851–61.

    CAS  PubMed  Google Scholar 

  40. Rambaud S, Nores JM, Meeus F, Paolaggi JA. Malignant papillomatosis of the bile ducts: a new indication for liver transplantation? Am J Gastroenterol. 1989;84:448–9.

    CAS  PubMed  Google Scholar 

  41. Goodman ZD, Ishak KG. Angiomyolipomas of the liver. Am J Surg Pathol. 1984;8:745–50.

    CAS  PubMed  Google Scholar 

  42. Nonomura A, Mizukami Y, Kadoya M, Matsui O, Shimizu K, Izumi R. Angiomyolipoma of the liver: a collective review. J Gastroenterol. 1994;29:95–105.

    CAS  PubMed  Google Scholar 

  43. Tsui WM, Colombari R, Portmann BC, Bonetti F, Thung SN, Ferrell LD, et al. Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol. 1999;23:34–48.

    CAS  PubMed  Google Scholar 

  44. Bonetti F, Pea M, Martignoni G, Zamboni G. The perivascular epithelioid cell and related lesions. Adv Anat Pathol. 1997;4:343–58.

    Google Scholar 

  45. Nguyen TT, Gormann B, Shileds D, Goodman Z. Malignant hepatic angiomyolipoma: report of case and review of literature. Am J Surg Pathol. 2008;32:793–8.

    PubMed  Google Scholar 

  46. Anthony PP, Telesinghe PU. Inflammatory pseudotumour of the liver. J Clin Pathol. 1986;39:761–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Horiuchi R, Uchida T, Kojima T, Shikata T. Inflammatory pseudotumor of the liver. Clinicopathologic study and review of the literature. Cancer. 1990;65:1583–90.

    CAS  PubMed  Google Scholar 

  48. Shek TW, Ng IO, Chan KW. Inflammatory pseudotumor of the liver. Report of four cases and review of the literature. Am J Surg Pathol. 1993;17:231–8.

    CAS  PubMed  Google Scholar 

  49. Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193–203.

    PubMed  Google Scholar 

  50. Zen Y, Fujii T, Sato Y, Masuda S, Nakanuma Y. Pathological classification of hepatic inflammatory pseudotumor, with respect to IgG4-related disease. Mod Pathol. 2007;20:884–94.

    PubMed  Google Scholar 

  51. Selves J, Meggetto F, Brousset P, Voigt JJ, Pradère B, Grasset D, et al. Inflammatory pseudotumor of the liver. Evidence for follicular dendritic reticulum cell proliferation associated with clonal Epstein-Barr virus. Am J Surg Pathol. 1996;20:747–53.

    CAS  PubMed  Google Scholar 

  52. Su LD, Atayde-Perez A, Sheldon S, Fletcher JA, Weiss SW. Inflammatory myofibroblastic tumor: cytogenetic evidence supporting clonal origin. Mod Pathol. 1998;11:364–8.

    CAS  PubMed  Google Scholar 

  53. Gonzalez-Ojeda A, Rodriguez-Alcantar DA, Arenas-Marquez H, Sanchez Perez-Verdia E, Chavez-Perez R, Alvarez-Quintero R, et al. Retained foreign bodies following intra-abdominal surgery. Hepatogastroenterology. 1999;46:808–12.

    CAS  PubMed  Google Scholar 

  54. Kalovidouris A, Kehagias D, Moulopoulos L, Gouliamos A, Pentea S, Vlahos L. Abdominal retained surgical sponges: CT appearance. Eur Radiol. 1999;9:1407–10.

    CAS  PubMed  Google Scholar 

  55. Shepherd NA, Lee G. Solitary necrotic nodules of the liver simulating hepatic metastases. J Clin Pathol. 1983;36:1181–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Berry CL. Solitary “necrotic nodule” of the liver: a probable pathogenesis. J Clin Pathol. 1985;38:1278–80.

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Sundaresan M, Lyons B, Akosa AB. “Solitary” necrotic nodules of the liver: an aetiology reaffirmed. Gut. 1991;32:1378–80.

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Tsui WM, Yuen RW, Chow LT, Tse CC. Solitary necrotic nodule of the liver: parasitic origin? J Clin Pathol. 1992;45:975–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Feldmeier H, Schuster A. Mini review: hookworm-related cutaneous larva migrans. Eur J Clin Microbiol Infect Dis. 2012;31:915–8.

    CAS  PubMed  Google Scholar 

  60. Liu Q, Li MW, Wang ZD, Zhao GH, Zhu XQ. Human sparganosis, a neglected food borne zoonosis. Lancet Infect Dis. 2015;15:1226–35.

    PubMed  Google Scholar 

  61. Macpherson CN. The epidemiology and public health importance of toxocariasis: a zoonosis of global importance. Int J Parasitol. 2013;43:999–1008.

    PubMed  Google Scholar 

  62. Maruyama H, Nawa Y, Noda S, Mimori T, Choi WY. An outbreak of visceral larva migrans due to Ascaris suum in Kyushu, Japan. Lancet. 1996;347:1766–7.

    CAS  PubMed  Google Scholar 

  63. Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003;16:265–72.

    PubMed  PubMed Central  Google Scholar 

  64. Pinelli E, Herremans T, Harms MG, Hoek D, Kortbeek LM. Toxocara and Ascaris seropositivity among patients suspected of visceral and ocular larva migrans in the Netherlands: trends from 1998 to 2009. Eur J Clin Microbiol Infect Dis. 2011;30:873–9.

    CAS  PubMed  Google Scholar 

  65. Baldisserotto M, Conchin CF, Soares Mda G, Araujo MA, Kramer B. Ultrasound findings in children with toxocariasis: report on 18 cases. Pediatr Radiol. 1999;29:316–9.

    CAS  PubMed  Google Scholar 

  66. Ishibashi H, Shimamura R, Hirata Y, Kudo J, Onizuka H. Hepatic granuloma in toxocaral infection: role of ultrasonography in hypereosinophilia. J Clin Ultrasound. 1992;20:204–10.

    CAS  PubMed  Google Scholar 

  67. Parsons JC, Bowman DD, Grieve RB. Tissue localization of excretory-secretory antigens of larval Toxocara canis in acute and chronic murine toxocariasis. Am J Trop Med Hyg. 1986;27:492–8.

    Google Scholar 

  68. Kaplan KJ, Goodman ZD, Ishak KG. Eosinophilic granuloma of the liver: a characteristic lesion with relationship to visceral larva migrans. Am J Surg Pathol. 2001;25:1316–21.

    CAS  PubMed  Google Scholar 

  69. de Savigny DH, Volle A, Woodruff AW. Toxocariasis: serological diagnosis by enzyme immunoassay. J Clin Pathol. 1979;32:284–8.

    PubMed  PubMed Central  Google Scholar 

  70. Magnaval JF, Fabre R, Maurieres P, Charlet JP, de Larrard B. Application of the western blotting procedure for the immunodiagnosis of human toxocariasis. Parasitol Res. 1991;77:697–702.

    CAS  PubMed  Google Scholar 

  71. Khuroo MS. Ascariasis. Gastroenterol Clin North Am. 1996;25:553–77.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgment

Prof. Alex Y. Chang was a coauthor of the first edition of this chapter.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wilson M. S. Tsui MD, FRCPath .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tsui, W.M.S., Mori, T., Iwai, M. (2019). Liver Tumor I: Benign Tumors and Tumor-Like Lesions. In: Hashimoto, E., Kwo, P., Suriawinata, A., Tsui, W., Iwai, M. (eds) Diagnosis of Liver Disease. Springer, Singapore. https://doi.org/10.1007/978-981-13-6806-6_16

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-6806-6_16

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-6805-9

  • Online ISBN: 978-981-13-6806-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics